Global Genetic Testing Market 2015-2020: Growing Prominence of DTC Genetic Testing: A Boon or a Curse?
DUBLIN, July 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/njbn65/genetic_testing) has announced the addition of the "Genetic Testing - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Genetic Testing in US$ Million by the following Product Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 86 companies including many key and niche players such as
- Abbott Laboratories (US)
- Abbott Molecular, Inc. (US)
- AutoGenomics, Inc. (US)
- BioRad Laboratories (US)
- ELITech Group S.P.A. (France)
- PerkinElmer, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics Corp. (Switzerland)
- Roche Molecular Diagnostics, Inc. (US)
- Thermo Fisher Scientific (US)
- Transgenomic, Inc. (US)
Key Topics Covered:
1. GLOBAL MARKET OVERVIEW
2. SEGMENTAL REVIEW
3. MARKET TRENDS
4. MOLECULAR DIAGNOSTICS MARKET
5. PRODUCT OVERVIEW
6. PRODUCT LAUNCHES/INNOVATIONS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 86 (including Divisions/Subsidiaries 90)
- The United States (58)
- Canada (4)
- Japan (1)
- Europe (21)
- - France (2)
- - Germany (3)
- - The United Kingdom (3)
- - Spain (1)
- - Rest of Europe (12)
- Asia-Pacific (Excluding Japan) (6)
For more information visit http://www.researchandmarkets.com/research/njbn65/genetic_testing
Media Contact:
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article